Mikhaila Rice, PharmD, BCPS (@MikhailaPharmD) reviews pathophysiology of gastrointestinal stromal tumors, describes the pharmacology of medications used to treat gastrointestinal stromal tumors and discusses the place in therapy of new treatment options, including ripretinib and avapritinib.

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.